ONO-AE5-599 - Moligand™ , Antagonist of EP 3 receptor, CAS No.O612533, Antagonist of EP 3 receptor

CAS: O612533 Cat. No.: O612533 PubChem CID: 73755159
Disponibile su ordine
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.
Storage
Room temperature
★
Size
Germania (EU)
USA*
Price
Qty
5mg
O612533-5mg
Su ordinazione · 8–12 settimane
694,10€
25mg
O612533-25mg
Su ordinazione · 8–12 settimane
1.488,09€
Enter a quantity for the sizes you want to add.
🧪

Why this grade

Moligand™ Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Room temperature Ships Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Specifications

Specifiche e purezza
Moligand™
Condizioni di conservazione di stoccaggio
Room temperature
Grado
Moligand™
Tipo di azione
ANTAGONIST
Meccanismo d'azione
Antagonist of EP 3 receptor
Nomi e identificatori
Sorrisi canoniciCC(C[C@H](c1cc(C)cc(c1)C)NC(=C)c1cc(ccc1CCC(=O)O)COc1ccccc1C)C
IUPAC Name3-[2-[1-[[(1R)-1-(3,5-dimethylphenyl)-3-methylbutyl]amino]ethenyl]-4-[(2-methylphenoxy)methyl]phenyl]propanoic acid
InChIKeyMIHNFQDPLQJFEZ-SSEXGKCCSA-N
INCHI1S/C32H39NO3/c1-21(2)15-30(28-17-22(3)16-23(4)18-28)33-25(6)29-19-26(11-12-27(29)13-14-32(34)35)20-36-31-10-8-7-9-24(31)5/h7-12,16-19,21,30,33H,6,13-15,20H2,1-5H3,(H,34,35)/t30-/m1/s1
Isomeri SMILES CC1=CC=CC=C1OCC2=CC(=C(C=C2)CCC(=O)O)C(=C)N[C@H](CC(C)C)C3=CC(=CC(=C3)C)C
PubChem CID 73755159

Documentazione

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassPhenylpropanoids and polyketides
ClassePhenylpropanoic acids
SubclassNot available
Intermediate Tree Nodes Not available
Direct ParentPhenylpropanoic acids
Alternative Parents m-Xylenes  Styrenes  Phenoxy compounds  Phenol ethers  Toluenes  Aralkylamines  Alkyl aryl ethers  Amino acids  Monocarboxylic acids and derivatives  Enamines  Dialkylamines  Carboxylic acids  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular FrameworkAromatic homomonocyclic compounds
Substituents 3-phenylpropanoic-acid - Phenoxy compound - M-xylene - Xylene - Phenol ether - Styrene - Alkyl aryl ether - Aralkylamine - Toluene - Monocyclic benzene moiety - Benzenoid - Amino acid or derivatives - Amino acid - Carboxylic acid derivative - Carboxylic acid - Secondary aliphatic amine - Enamine - Ether - Monocarboxylic acid or derivatives - Secondary amine - Organic oxygen compound - Amine - Organic oxide - Carbonyl group - Organonitrogen compound - Organooxygen compound - Hydrocarbon derivative - Organic nitrogen compound - Aromatic homomonocyclic compound
DescrizioneThis compound belongs to the class of organic compounds known as phenylpropanoic acids. These are compounds with a structure containing a benzene ring conjugated to a propanoic acid.
External Descriptors Not available
Struttura 3D
Modello di struttura chimica interattiva





Obiettivi associati (umani)
PTGER3 Tclin Prostaglandin E2 receptor EP3 subtype (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

No item-specific, validated protocols are provided for ONO-AE5-599. The following are general, non-binding guidelines for handling small-molecule ligands in research.

  • Stock preparation (general)

    • Weigh the required amount quickly to limit air/light exposure. Prepare a 10–50 mM stock in DMSO (or alternative solvent validated for your assay). Vortex and, if needed, sonicate briefly. Optionally sterile-filter through 0.22 µm PTFE.
  • Working solutions

    • Dilute into assay buffer or media to the desired final concentration, keeping vehicle (e.g., DMSO) at a constant percentage across samples (commonly 0.1–0.5% v/v; do not exceed your assay tolerance).
  • Controls

    • Include vehicle-only controls and, if known, a reference compound affecting the same pathway/target. Run a serial dilution (10-point, half-log spacing) for concentration–response analysis.
  • Stability checks

    • Assess short-term stability (room temperature, assay duration) by LC–MS/HPLC. For light-sensitive compounds, protect with amber vials/foil.
  • Documentation

    • Record batch/lot, solvent, concentration, preparation date, and storage conditions in your ELN.
  • Disclaimer

    • These steps are general guidance and are not item-specific validated protocols. Always adapt to your assay SOPs and consult the CoA/SDS.
Biological Roles
  • From Product Data (item-specific)

    • Biological target, pathway, and mechanism: Not specified for this item; refer to CoA/Spec Sheet and primary literature (PubChem CID 73755159).
  • General considerations for Moligand-type small molecules

    • Such ligands are often used as pathway probes, receptor modulators, or enzyme inhibitors/activators in discovery research. However, without a verified structure/annotation, no specific biological role can be assigned here.
    • Prior to experimental use, confirm: the exact structure, salt/tautomeric form, stereochemistry, and any known on/off-targets from peer-reviewed literature or trusted databases.
  • Practical guidance

    • Establish a vehicle control and, where possible, a pharmacological control (compound with known effect on the hypothesized target) to contextualize results.
    • Perform a concentration–response study spanning at least 3–4 orders of magnitude to estimate potency and window for on-target effects vs. cytotoxicity.
    • Validate activity in orthogonal assays (biochemical vs. cellular) to mitigate false positives driven by assay interference (fluorescence quenching, redox cycling, aggregation). Employ counter-screens if PAINS-like motifs are suspected (once structure is confirmed).
Buffer Applications

This product is not a buffer component. However, buffers are commonly used as vehicles for small-molecule testing.

  • Applicability to this item

    • Buffering capacity or pH ranges are not applicable to ONO-AE5-599 itself.
  • Practical guidance for assay buffers (general)

    • Choose a buffer that supports target stability and readout (e.g., HEPES or PBS for cell assays; Tris, HEPES, or phosphate for enzymology) and does not react with the compound.
    • Maintain a consistent vehicle percentage (e.g., 0.1–1% DMSO) across controls and treatments to avoid solvent artifacts.
    • Filter-sterilize working solutions if required and verify compound stability in the buffer over the assay timescale by LC–MS/HPLC.
  • Recipes and pH ranges

    • Specific buffer recipes are assay-dependent and not tied to this compound. Refer to your assay SOPs and validated conditions.
Green Alternatives

Because ONO-AE5-599 is a bioactive small molecule rather than a process solvent or reagent, “green alternatives” primarily concern the choice of vehicle and sample handling.

  • Greener solvent considerations for stock/dilution (general guidance)

    • Prefer water-based buffers with minimal co-solvent when feasible. Use the lowest effective DMSO content (e.g., 0.1–0.5% v/v final) compatible with solubility.
    • Where DMSO is unnecessary, consider ethanol at low percentages as a more readily biodegradable vehicle; verify biological compatibility.
    • Non-volatile co-solvents like PEG 300/400 at low levels (1–5%) can reduce VOC emissions but may affect assay readouts.
  • Operational green practices

    • Prepare small aliquots to reduce waste and repeated thawing.
    • Use micro-scale solubility scouting to avoid over-preparation of unstable stocks.
    • Consolidate shipments with other catalog items to reduce packaging and transport impact when possible.
  • Trade-offs

    • Lower-VOC systems (PEG/water) can alter permeability or enzyme kinetics; DMSO provides superior solubilization but at higher eco-tox and worker exposure concerns. Balance solvent selection with assay fidelity and EHS policy.
  • Item-specific greener substitutes

    • Not applicable; this is a discrete small molecule ligand. Selection of alternative compounds would be based on pharmacology/assay needs rather than green chemistry per se.
Pharmaceutical Uses
  • From Product Data (item-specific)

    • Research Use Note: For research use only
  • Context and limitations

    • No pharmacopeial status, excipient role, or manufacturing use is provided. This item is not intended for human or veterinary use, clinical diagnostics, or as an API/excipient.
  • Typical research roles for similar items (general)

    • May serve as a reference standard or tool compound during discovery screening, target validation, and method development (e.g., LC–MS reference), contingent on verified identity and purity from the CoA.
  • Compliance notes

    • For GLP/GMP or regulated applications, obtain and review full documentation (CoA, SDS, impurity profile). If such documentation is not available, limit use to exploratory, non-regulated research.
Physical Properties

Item-specific physicochemical data have not been provided in the current listing. Do not assume values for assay planning—verify against the CoA/Spec Sheet or primary databases.

  • From Product Data (item-specific)

    • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Literature/computed properties (non-item-specific)

    • Boiling point, melting point, density, pKa, logP/logD, refractive index: Not available here. Consult PubChem CID 73755159 or vendor CoA for authoritative values.
    • Solubility guidance (general): Many screening ligands are most soluble in DMSO (10–100 mM stock common), variably soluble in methanol/ethanol, and may have limited aqueous solubility unless ionizable or formulated with co-solvents/surfactants.
  • Practical notes (general guidance)

    • Begin with a small-scale solubility check (e.g., 10 mM target in DMSO). If precipitation occurs upon aqueous dilution, titrate with co-solvent (DMSO 0.1–1% v/v final), gentle warming (≤40 °C), or surfactant (0.01–0.1% Tween-80) as permitted by your assay.
    • Avoid pH manipulation unless the compound is known to be ionizable and stable under the chosen pH range. Always document vehicle percentage for biological assays.
Quality and Grades
  • From Product Data (item-specific)

    • Grade/Purity: Moligand™
  • What Moligand™ typically signifies (general description; not a specification)

    • Moligand-grade materials are intended for use as research ligands or small-molecule tools in screening, target validation, or assay development. Suppliers commonly emphasize identity confirmation (e.g., LC–MS, MS/MS, and/or NMR) and suitability for biological testing when prepared as DMSO stocks. Exact acceptance criteria (purity %, residual solvents, water, salts) vary by catalog item and must be confirmed on the CoA.
  • Interpreting grade for your application (guidance)

    • For biochemical/cellular assays, typical expectations include high identity confidence and adequate purity to avoid off-target artifacts. If you require low nonvolatile residue or low UV background (e.g., analytical detection), request the CoA for purity method, chromatographic profile, and any stabilizers/additives.
    • If intended as a reference standard, verify mass balance (salt content, water of hydration) and the precise form (free base/acid, salt, solvate, polymorph) on the CoA.
  • Stabilizers and additives

    • None are listed. If stabilizers or antioxidants are present, they will be declared on the CoA/Spec Sheet. Absent such information, assume neat solid or solution as supplied and validate before regulated uses.
Reaction and Applications

This product is positioned as a research ligand for screening rather than as a synthetic reagent.

  • From Product Data (item-specific)

    • Category: Small molecules and compound libraries (小分子和化合物库)
  • Typical applications for Moligand-type items (general guidance)

    • Assay development: Use as a tool compound or hit candidate in biochemical/cellular assays to probe pathway responses, binding, or phenotypes.
    • SAR exploration: Benchmark against analogs to establish preliminary structure–activity relationships.
    • Reference control: Serve as positive/negative control where the mechanism/target is known from literature (verify target from primary sources for this specific compound).
  • Not typically used for

    • Named organic reactions or stoichiometric reagents (e.g., Grignard, reductions, couplings). If you require a building block or reagent, consult the corresponding synthetic-grade catalog.
  • Practical notes (general)

    • Prepare concentrated DMSO stocks, filter-sterilize if needed (PTFE, 0.22 µm; avoid adsorption losses by pre-wetting), and store aliquots to minimize freeze–thaw.
    • Confirm chemical stability under assay conditions (light, pH, reducing/oxidizing environments) via quick LC–MS or HPLC checks prior to large screens.
Reaction Conditions

Not applicable as a reaction reagent.

  • From Product Data (item-specific)

    • No reaction-use guidance is provided.
  • General note

    • If you plan to use ONO-AE5-599 in chemical transformations (e.g., as a substrate or coupling partner), first retrieve its definitive structure and functional groups from the CoA or PubChem, then consult reaction-specific literature for compatible solvents, temperatures, and catalysts. Absent such information, no conditions can be responsibly recommended.
Safety and Handling

Safety data specific to ONO-AE5-599 are not included in this listing. Treat as a bioactive small molecule of unknown hazard until the SDS is reviewed.

  • From Product Data (item-specific)

    • GHS classification/signal word/pictograms/H-statements: Not specified for this item; refer to SDS.
    • Storage conditions: Room temperature (per listing)
  • General laboratory precautions (not item-specific; follow your institutional EHS)

    • PPE: lab coat, safety glasses, and nitrile gloves. Use in a chemical fume hood to avoid inhalation of dust/aerosols and solvent vapors.
    • DMSO warning: Many small molecules readily permeate skin when dissolved in DMSO; avoid skin contact with solutions.
    • Incompatibilities: Unknown for this item; as a precaution, segregate from strong oxidizers/reducers and acids/bases until stability is confirmed.
    • First aid (general): In case of skin/eye contact, rinse with water for ≥15 minutes; remove contaminated clothing. If inhaled, move to fresh air. If ingested, seek medical attention. Always present the SDS to medical personnel.
    • Spill response: Absorb with inert material (vermiculite), collect in a compatible waste container. Decontaminate area with appropriate solvent while wearing PPE.
  • Authoritative source

    • Always defer to the product-specific SDS and CoA/Spec Sheet for definitive hazards, handling, and disposal guidance.
Solvent Selection

With no structure or solubility data provided, start with a conservative, assay-friendly solvent strategy and document vehicle percentages rigorously.

  • General solvent hierarchy for small-molecule ligands (guidance)

    • Primary: DMSO (widely compatible with biochemical and cell assays); prepare 10–50 mM stocks if solubility allows.
    • Secondary: DMF, methanol, or ethanol for stock preparation if DMSO solubility is poor. Confirm assay compatibility.
    • Aqueous systems: If the compound is ionizable, aqueous buffers (pH-adjusted) or co-solvent systems (DMSO 0.1–1% v/v) can work. Consider solubilization aids (0.01–0.1% polysorbate 80, 1–5% PEG 400) as permitted.
  • Practical workflow

    • Perform a tiered solubility screen (DMSO → MeOH/EtOH → DMF) at small scale, monitoring clarity after vortexing/sonication and after dilution into the intended buffer or media.
    • Record precipitation onset during aqueous dilution to set maximum permitted vehicle content.
  • Comparison notes (general)

    • DMSO vs ethanol: DMSO offers broader solubility but can impact membrane permeability and enzyme activity at >1–2% v/v; ethanol is more volatile and may alter assay outcomes at ≥0.5–1%.
    • DMF offers strong solvation but is less favored biologically; limit final DMF to ≤0.1–0.5% if used.
  • Documentation

    • Capture solvent lot, vehicle %, and any pH adjustments in your ELN. Validate that controls contain identical vehicle conditions.
Storage and Reconstitution
  • From Product Data (item-specific)

    • Storage conditions: Room temperature
    • Shipped in: Not specified for this item; refer to CoA/Spec Sheet.
  • General guidance for small-molecule ligands (non-item-specific)

    • Solid form: Store in original, tightly closed container, desiccated and protected from light. If hygroscopic or light-sensitive (unknown here), use a desiccator and amber vialing.
    • Solution stocks: Prepare aliquots (e.g., 100–500 µL) at 10–50 mM in DMSO; store at −20 °C to −80 °C to extend shelf life. Avoid repeated freeze–thaw by using single-use aliquots.
    • Reconstitution: Add calculated volume of solvent to achieve the desired molarity, based on the molecular weight listed on the CoA. If MW is not available, obtain it from PubChem CID 73755159 before preparing molar stocks.
  • Stability notes

    • Item-specific stability (thermal, oxidative, photolytic) is not specified. Perform a small-scale stability assessment under intended storage and assay conditions.
  • Labeling and tracking

    • Label with compound name, lot/batch, concentration, solvent, preparation date, and storage temperature. Retain CoA and SDS with the stored material for compliance and traceability.
Structure and Identity

Brief overview: ONO-AE5-599 is supplied as a Moligand-grade small molecule for research screening. Structural descriptors are not provided in the current listing.

  • From Product Data

    • Product name: ONO-AE5-599 (SKU: O612533)
    • CAS: O612533 (catalog placeholder; not a standard CAS registry number)
    • PubChem CID: 73755159
    • InChIKey: 219846 (truncated/atypical format as provided)
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural features (general note)

    • Specific functional groups, ring systems, stereochemistry, and 2D connectivity are not provided in the current product entry. Please consult the CoA/Spec Sheet or the PubChem record (CID 73755159) for definitive structure and identifiers.
  • How to describe the 2D structure (guidance)

    • Without a SMILES/InChI or structure image, detailed verbal description is not possible. If needed, extract the canonical SMILES from PubChem CID 73755159 to infer heterocycles, substitution pattern, and potential ionizable groups for downstream handling (solubility, pKa, and storage considerations).
Synthetic Utility

This product is offered as a bioactive small-molecule ligand rather than as a synthetic building block or reagent.

  • Applicability

    • Named transformations, protecting-group strategies, and reagent behavior are not typically applicable without a confirmed structure and functional group profile.
  • Guidance if derivatization is intended (general)

    • Obtain the full structure (from CoA or PubChem CID 73755159) and assess reactive handles (e.g., phenols, amines, carboxylates, halides) before planning conjugation or prodrug strategies.
    • If used for probe development (e.g., biotinylation, fluorophore tagging), map SAR to avoid modifying pharmacophore-essential positions. Confirm activity is retained post-derivatization.
    • Use orthogonal analytics (LC–MS, HRMS, NMR) to verify integrity after any modification.
  • Bottom line

    • In the absence of structure and reactivity data, treat synthetic applications as out-of-scope for this catalog item.
Target Specificity
  • From Product Data (item-specific)

    • Target, family/class, binding mode, species selectivity, and potency: Not specified for this item; refer to CoA/Spec Sheet and primary literature (PubChem CID 73755159).
  • Guidance (general)

    • Before using as a tool compound, verify the annotated target(s), selectivity over related family members, and any reported off-targets. Cross-check mechanistic claims with independent publications.
    • Where available, compile KD/IC50/EC50 across orthogonal assay formats to assess robustness and potential assay interference.

Need help choosing the grade?

Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.

View Moligand™ grade guide →

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.